Roundview Capital’s Amgen AMGN Stock Holding History

Roundview Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$309K	Sell	877 -9	-1%	-$3.21K	0.02%	299
2025 Q4	$290K	Buy	886 +138	+18%	+$43.8K	0.02%	294
2025 Q3	$211K	Buy	+748	New	+$217K	0.01%	324
2025 Q2	–	Sell	-806	Closed	-$251K	–	326
2025 Q1	$251K	Sell	806 -75	-9%	-$22.1K	0.02%	290
2024 Q4	$230K	Sell	881 -19	-2%	-$5.64K	0.02%	313
2024 Q3	$290K	Buy	900 +19	+2%	+$6.21K	0.02%	303
2024 Q2	$275K	Hold	881	–	–	0.02%	293
2024 Q1	$250K	Sell	881 -11	-1%	-$3.22K	0.02%	297
2023 Q4	$257K	Sell	892 -440	-33%	-$120K	0.02%	290
2023 Q3	$358K	Sell	1,332 -50	-4%	-$12.5K	0.04%	259
2023 Q2	$307K	Sell	1,382 -59	-4%	-$13.7K	0.03%	271
2023 Q1	$348K	Sell	1,441 -1,275	-47%	-$313K	0.04%	263
2022 Q4	$713K	Sell	2,716 -779	-22%	-$209K	0.08%	210
2022 Q3	$788K	Sell	3,495 -4,878	-58%	-$1.18M	0.1%	184
2022 Q2	$2.04M	Sell	8,373 -10	-0.1%	-$2.45K	0.24%	107
2022 Q1	$2.03M	Buy	8,383 +107	+1%	+$24.6K	0.21%	122
2021 Q4	$1.86M	Sell	8,276 -138	-2%	-$29.1K	0.19%	132
2021 Q3	$1.79M	Sell	8,414 -66	-0.8%	-$15.2K	0.2%	130
2021 Q2	$2.07M	Buy	8,480 +492	+6%	+$121K	0.23%	113
2021 Q1	$1.99M	Hold	7,988	–	–	0.25%	109
2020 Q4	$1.84M	Buy	7,988 +312	+4%	+$71.9K	0.25%	97
2020 Q3	$1.95M	Hold	7,676	–	–	0.31%	77
2020 Q2	$1.81M	Buy	7,676 +71	+0.9%	+$16.2K	0.31%	84
2020 Q1	$1.54M	Buy	7,605 +79	+1%	+$17.3K	0.33%	78
2019 Q4	$1.81M	Buy	7,526 +20	+0.3%	+$4.41K	0.34%	89
2019 Q3	$1.45M	Sell	7,506 -987	-12%	-$189K	0.31%	93
2019 Q2	$1.56M	Buy	8,493 +2,865	+51%	+$513K	0.35%	86
2019 Q1	$1.07M	Buy	5,628 +223	+4%	+$42.6K	0.25%	106
2018 Q4	$1.05M	Buy	5,405 +556	+11%	+$108K	0.3%	93
2018 Q3	$1M	Buy	4,849 +375	+8%	+$73.9K	0.25%	112
2018 Q2	$826K	Buy	4,474 +1,380	+45%	+$244K	0.22%	126
2018 Q1	$527K	Buy	+3,094	New	+$568K	0.15%	151
2017 Q3	–	Sell	-6,497	Closed	-$1.12M	–	214
2017 Q2	$1.12M	Sell	6,497 -690	-10%	-$112K	0.33%	91
2017 Q1	$1.18M	Buy	7,187 +400	+6%	+$66.5K	0.37%	91
2016 Q4	$992K	Sell	6,787 -7,485	-52%	-$1.13M	0.32%	96
2016 Q3	$2.38M	Buy	14,272 +70	+0.5%	+$11.8K	0.84%	34
2016 Q2	$2.16M	Buy	14,202 +300	+2%	+$46.6K	0.8%	39
2016 Q1	$2.08M	Sell	13,902 -524	-4%	-$77.8K	0.78%	39
2015 Q4	$2.34M	Buy	+14,426	New	+$2.27M	0.93%	27
2014 Q3	–	Sell	-14,726	Closed	-$1.74M	–	128
2014 Q2	$1.74M	Buy	+14,726	New	+$1.7M	0.7%	42
2014 Q1	–	Sell	-10,774	Closed	-$1.23M	–	126
2013 Q4	$1.23M	Sell	10,774 -400	-4%	-$45.5K	0.56%	62
2013 Q3	$1.25M	Buy	11,174 +1,150	+11%	+$125K	0.65%	54
2013 Q2	$989K	Buy	+10,024	New	+$1.04M	0.62%	54

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Roundview Capital's AMGN Position: Q1 2026 in Review

Roundview Capital reduced its Amgen (AMGN) stake by 1% in Q1 2026, selling an estimated $3.21K and leaving 877 shares worth $309K. The position accounts for 0.02% of the portfolio, ranked #299.

Roundview Capital first reported a position in AMGN in Q2 2013 and has held it in 43 quarters since. The position peaked at $2.38M in Q3 2016. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Roundview Capital held 877 shares of Amgen worth $309K as of Q1 2026.
Roundview Capital sold 9 Amgen shares in Q1 2026, an estimated $3.21K.
Amgen made up 0.02% of Roundview Capital's portfolio in Q1 2026, its #299 holding.
Roundview Capital first reported a position in Amgen in Q2 2013 and has held it in 43 quarters since.
Roundview Capital's Amgen position peaked at $2.38M in Q3 2016.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Roundview Capital's 13F filing for Q1 2026, filed 8 May 2026.